The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Follicle Stimulating Hormone-Global Market Insights and Sales Trends 2025
Synopsis
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
The global Follicle Stimulating Hormone market size is expected to reach US$ 1550.6 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Follicle Stimulating Hormone in various end use industries. The expanding demands from the Infertility Treatment and Assisted Reproductive Technology, are propelling Follicle Stimulating Hormone market. Recombinant FSH, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Urinary FSH segment is estimated at % CAGR for the next seven-year period.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Follicle Stimulating Hormone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Follicle Stimulating Hormone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Follicle Stimulating Hormone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Follicle Stimulating Hormone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Follicle Stimulating Hormone covered in this report include Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter and Teva, etc.
The global Follicle Stimulating Hormone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Global Follicle Stimulating Hormone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Follicle Stimulating Hormone market, Segment by Type:
Recombinant FSH
Urinary FSH
Global Follicle Stimulating Hormone market, by Application
Infertility Treatment
Assisted Reproductive Technology
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
The global Follicle Stimulating Hormone market size is expected to reach US$ 1550.6 million by 2029, growing at a CAGR of 2.8% from 2023 to 2029. The market is mainly driven by the significant applications of Follicle Stimulating Hormone in various end use industries. The expanding demands from the Infertility Treatment and Assisted Reproductive Technology, are propelling Follicle Stimulating Hormone market. Recombinant FSH, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Urinary FSH segment is estimated at % CAGR for the next seven-year period.
Due to less pollution, recombinant FSH takes large proportion in market. In 2019, recombinant FSH takes about 82% of Poland follicle stimulating hormone consumption market share.
There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are Top 2 companies in the world. In 2019, Merck Serono takes about 55% of Poland follicle stimulating hormone revenue. MSD takes about 18% of Poland follicle stimulating hormone revenue.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Follicle Stimulating Hormone, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Follicle Stimulating Hormone market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Follicle Stimulating Hormone market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Follicle Stimulating Hormone sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Follicle Stimulating Hormone covered in this report include Merck Serono, MSD, IBSA, Ferring, Livzon, Techwell, GenSci, Gedeon Richter and Teva, etc.
The global Follicle Stimulating Hormone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck Serono
MSD
IBSA
Ferring
Livzon
Techwell
GenSci
Gedeon Richter
Teva
Global Follicle Stimulating Hormone market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Follicle Stimulating Hormone market, Segment by Type:
Recombinant FSH
Urinary FSH
Global Follicle Stimulating Hormone market, by Application
Infertility Treatment
Assisted Reproductive Technology
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Follicle Stimulating Hormone manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Follicle Stimulating Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Follicle Stimulating Hormone Market Overview
1.1 Follicle Stimulating Hormone Product Overview
1.2 Follicle Stimulating Hormone Market Segment by Type
1.2.1 Recombinant FSH
1.2.2 Urinary FSH
1.3 Global Follicle Stimulating Hormone Market Size by Type
1.3.1 Global Follicle Stimulating Hormone Market Size Overview by Type (2018-2029)
1.3.2 Global Follicle Stimulating Hormone Historic Market Size Review by Type (2018-2023)
1.3.3 Global Follicle Stimulating Hormone Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.2 Europe Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Follicle Stimulating Hormone Sales Breakdown by Type (2018-2023)
2 Global Follicle Stimulating Hormone Market Competition by Company
2.1 Global Top Players by Follicle Stimulating Hormone Sales (2018-2023)
2.2 Global Top Players by Follicle Stimulating Hormone Revenue (2018-2023)
2.3 Global Top Players by Follicle Stimulating Hormone Price (2018-2023)
2.4 Global Top Manufacturers Follicle Stimulating Hormone Manufacturing Base Distribution, Sales Area, Product Type
2.5 Follicle Stimulating Hormone Market Competitive Situation and Trends
2.5.1 Follicle Stimulating Hormone Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Follicle Stimulating Hormone Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Follicle Stimulating Hormone as of 2022)
2.7 Date of Key Manufacturers Enter into Follicle Stimulating Hormone Market
2.8 Key Manufacturers Follicle Stimulating Hormone Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Follicle Stimulating Hormone Status and Outlook by Region
3.1 Global Follicle Stimulating Hormone Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Follicle Stimulating Hormone Historic Market Size by Region
3.2.1 Global Follicle Stimulating Hormone Sales in Volume by Region (2018-2023)
3.2.2 Global Follicle Stimulating Hormone Sales in Value by Region (2018-2023)
3.2.3 Global Follicle Stimulating Hormone Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Follicle Stimulating Hormone Forecasted Market Size by Region
3.3.1 Global Follicle Stimulating Hormone Sales in Volume by Region (2024-2029)
3.3.2 Global Follicle Stimulating Hormone Sales in Value by Region (2024-2029)
3.3.3 Global Follicle Stimulating Hormone Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Follicle Stimulating Hormone by Application
4.1 Follicle Stimulating Hormone Market Segment by Application
4.1.1 Infertility Treatment
4.1.2 Assisted Reproductive Technology
4.2 Global Follicle Stimulating Hormone Market Size by Application
4.2.1 Global Follicle Stimulating Hormone Market Size Overview by Application (2018-2029)
4.2.2 Global Follicle Stimulating Hormone Historic Market Size Review by Application (2018-2023)
4.2.3 Global Follicle Stimulating Hormone Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.2 Europe Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Follicle Stimulating Hormone Sales Breakdown by Application (2018-2023)
5 North America Follicle Stimulating Hormone by Country
5.1 North America Follicle Stimulating Hormone Historic Market Size by Country
5.1.1 North America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
5.1.3 North America Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
5.2 North America Follicle Stimulating Hormone Forecasted Market Size by Country
5.2.1 North America Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
5.2.2 North America Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
6 Europe Follicle Stimulating Hormone by Country
6.1 Europe Follicle Stimulating Hormone Historic Market Size by Country
6.1.1 Europe Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
6.1.3 Europe Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
6.2 Europe Follicle Stimulating Hormone Forecasted Market Size by Country
6.2.1 Europe Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
6.2.2 Europe Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
7 Asia-Pacific Follicle Stimulating Hormone by Region
7.1 Asia-Pacific Follicle Stimulating Hormone Historic Market Size by Region
7.1.1 Asia-Pacific Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Follicle Stimulating Hormone Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Follicle Stimulating Hormone Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Follicle Stimulating Hormone Forecasted Market Size by Region
7.2.1 Asia-Pacific Follicle Stimulating Hormone Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Follicle Stimulating Hormone Sales in Value by Region (2024-2029)
8 Latin America Follicle Stimulating Hormone by Country
8.1 Latin America Follicle Stimulating Hormone Historic Market Size by Country
8.1.1 Latin America Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
8.1.3 Latin America Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
8.2 Latin America Follicle Stimulating Hormone Forecasted Market Size by Country
8.2.1 Latin America Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
8.2.2 Latin America Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
9 Middle East and Africa Follicle Stimulating Hormone by Country
9.1 Middle East and Africa Follicle Stimulating Hormone Historic Market Size by Country
9.1.1 Middle East and Africa Follicle Stimulating Hormone Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Follicle Stimulating Hormone Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Follicle Stimulating Hormone Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Follicle Stimulating Hormone Forecasted Market Size by Country
9.2.1 Middle East and Africa Follicle Stimulating Hormone Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Follicle Stimulating Hormone Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck Serono
10.1.1 Merck Serono Company Information
10.1.2 Merck Serono Introduction and Business Overview
10.1.3 Merck Serono Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Serono Follicle Stimulating Hormone Products Offered
10.1.5 Merck Serono Recent Development
10.2 MSD
10.2.1 MSD Company Information
10.2.2 MSD Introduction and Business Overview
10.2.3 MSD Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.2.4 MSD Follicle Stimulating Hormone Products Offered
10.2.5 MSD Recent Development
10.3 IBSA
10.3.1 IBSA Company Information
10.3.2 IBSA Introduction and Business Overview
10.3.3 IBSA Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.3.4 IBSA Follicle Stimulating Hormone Products Offered
10.3.5 IBSA Recent Development
10.4 Ferring
10.4.1 Ferring Company Information
10.4.2 Ferring Introduction and Business Overview
10.4.3 Ferring Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Ferring Follicle Stimulating Hormone Products Offered
10.4.5 Ferring Recent Development
10.5 Livzon
10.5.1 Livzon Company Information
10.5.2 Livzon Introduction and Business Overview
10.5.3 Livzon Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Livzon Follicle Stimulating Hormone Products Offered
10.5.5 Livzon Recent Development
10.6 Techwell
10.6.1 Techwell Company Information
10.6.2 Techwell Introduction and Business Overview
10.6.3 Techwell Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Techwell Follicle Stimulating Hormone Products Offered
10.6.5 Techwell Recent Development
10.7 GenSci
10.7.1 GenSci Company Information
10.7.2 GenSci Introduction and Business Overview
10.7.3 GenSci Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GenSci Follicle Stimulating Hormone Products Offered
10.7.5 GenSci Recent Development
10.8 Gedeon Richter
10.8.1 Gedeon Richter Company Information
10.8.2 Gedeon Richter Introduction and Business Overview
10.8.3 Gedeon Richter Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Gedeon Richter Follicle Stimulating Hormone Products Offered
10.8.5 Gedeon Richter Recent Development
10.9 Teva
10.9.1 Teva Company Information
10.9.2 Teva Introduction and Business Overview
10.9.3 Teva Follicle Stimulating Hormone Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Teva Follicle Stimulating Hormone Products Offered
10.9.5 Teva Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Follicle Stimulating Hormone Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Follicle Stimulating Hormone Industrial Chain Analysis
11.4 Follicle Stimulating Hormone Market Dynamics
11.4.1 Follicle Stimulating Hormone Industry Trends
11.4.2 Follicle Stimulating Hormone Market Drivers
11.4.3 Follicle Stimulating Hormone Market Challenges
11.4.4 Follicle Stimulating Hormone Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Follicle Stimulating Hormone Distributors
12.3 Follicle Stimulating Hormone Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
